1. Home
  2. TYRA vs MBC Comparison

TYRA vs MBC Comparison

Compare TYRA & MBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tyra Biosciences Inc.

TYRA

Tyra Biosciences Inc.

HOLD

Current Price

$18.55

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Logo MasterBrand Inc.

MBC

MasterBrand Inc.

SELL

Current Price

$6.73

Market Cap

1.4B

Sector

Industrials

ML Signal

SELL

Company Overview

Basic Information
Metric
TYRA
MBC
Founded
2018
1954
Country
United States
United States
Employees
N/A
12000
Industry
Biotechnology: Pharmaceutical Preparations
Agricultural Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.4B
IPO Year
2021
2022

Fundamental Metrics

Financial Performance
Metric
TYRA
MBC
Price
$18.55
$6.73
Analyst Decision
Strong Buy
Hold
Analyst Count
15
2
Target Price
★ $47.45
$9.63
AVG Volume (30 Days)
725.2K
★ 3.0M
Earning Date
11-04-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ N/A
Revenue
N/A
★ $2,734,700,000.00
Revenue This Year
N/A
$27.96
Revenue Next Year
N/A
$19.09
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 1.27
52 Week Low
$13.35
$6.17
52 Week High
$40.65
$13.96

Technical Indicators

Market Signals
Indicator
TYRA
MBC
Relative Strength Index (RSI) 31.90 42.24
Support Level N/A $6.61
Resistance Level $27.00 $7.31
Average True Range (ATR) 0.89 0.29
MACD -0.10 0.04
Stochastic Oscillator 5.38 58.08

Price Performance

Historical Comparison
TYRA
MBC

About TYRA Tyra Biosciences Inc.

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines for large opportunities in targeted oncology and genetically defined conditions, harnessing the power of Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are FGFR3, FGFR4/3, and FGFR1/2/3: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.

About MBC MasterBrand Inc.

MasterBrand Inc operates as a residential cabinet manufacturer in North America. It offers a comprehensive portfolio of residential cabinetry products for the kitchen, bathroom, and other parts of the home. The firm sells its products throughout the United States and Canada through three primary channels: dealers, retailers and builders.

Share on Social Networks: